Concepedia

Krisztina Kisfalvi

KK

17

Publications

1.7K

Citations

15

H-Index

1998

Active since

Affiliations

University of California, Los Angeles(Current)

Takeda (United States)

University of California San Diego

KU Leuven

Kitasato University

Krisztina Kisfalvi is an author at University of California, Los Angeles specializing in medicine, pharmacology, and cell signaling.

Top concepts

Publications per year

1998–2021

17

Publications

17

Metformin Disrupts Crosstalk between G Protein–Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth

Krisztina Kisfalvi, Guido Eibl, James Sinnett‐Smith et al. · Cancer Research · 2009 · 315 citations · Full text

Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis

William J. Sandborn, Filip Baert, Silvio Danese et al. · Gastroenterology · 2019 · 300 citations · Full text

Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer

Enrique Rozengurt, James Sinnett‐Smith, Krisztina Kisfalvi · Clinical Cancer Research · 2010 · 247 citations · Full text

, , +17

Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn’s Disease: Results From the VISIBLE 2 Randomised Trial

Séverine Vermeire, Geert D’Haens, Filip Baert et al. · Journal of Crohn s and Colitis · 2021 · 162 citations · Full text

Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells

Heloisa P. Soares, Yang Ni, Krisztina Kisfalvi et al. · PLoS ONE · 2013 · 128 citations · Full text

, , +17

Rows per page

1–5 of 17